March 10, 2025 · Form 4 insider transaction
Celadon Partners SPV 24 bought 9,777,000 shares of Senti Biosciences Holdings, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each share of Series A Convertible Preferred Stock (the "Series A Preferred Stock") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date.